Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes ...
Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...
Wild axolotls are facing extinction. That’s the bad news. But take heart: Cutie-pie axolotls bred in captivity may be able to ...
Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst ...
Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion to expand its vascular ...
With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback